SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A0C27CC3B26BF972DFEB48901495B00EE7E4EFD9AC3FF50E4F9D8667A5C5E17F5C5991A061AC9FEC17D40AFE542E7C00>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A0C27CC3B26BF972DFEB48901495B00EE7E4EFD9AC3FF50E4F9D8667A5C5E17F5C5991A061AC9FEC17D40AFE542E7C00
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A0C27CC3B26BF972DFEB48901495B00EE7E4EFD9AC3FF50E4F9D8667A5C5E17F5C5991A061AC9FEC17D40AFE542E7C00
http://www.w3.org/2000/01/rdf-schema#comment
"Demonstrate a requirement for IRF5 in the development of SLE via its role in B cells. Antinuclear autoantibodies and Ig glomerular deposits hallmarks of SLE are absent in Irf5(-/-) mice challenged to develop SLE by pristane injection."
xsd:string
http://purl.uniprot.org/uniprot/#_A905C1B13106D6AC76905E58320EB0DB96B8E199D28C59AFB73053D074992308585DB9FD5CBB4DA1B0F2308443B723D6
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A0C27CC3B26BF972DFEB48901495B00EE7E4EFD9AC3FF50E4F9D8667A5C5E17F5C5991A061AC9FEC17D40AFE542E7C00
http://purl.uniprot.org/uniprot/Q3U169
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A0C27CC3B26BF972DFEB48901495B00EE7E4EFD9AC3FF50E4F9D8667A5C5E17F5C5991A061AC9FEC17D40AFE542E7C00
http://purl.uniprot.org/uniprot/#_Q3U169-mappedCitation-20479222
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A0C27CC3B26BF972DFEB48901495B00EE7E4EFD9AC3FF50E4F9D8667A5C5E17F5C5991A061AC9FEC17D40AFE542E7C00